Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Byetta and Bydureon Lawsuit Against AstraZeneca Byetta and Bydureon, GLP-1 receptor agonist drugs manufactured by AstraZeneca, were marketed as prescription drugs to treat type 2 diabetes and improve blood sugar control
By leveraging patent thickets aimed at extending the market monopolies on their blockbuster drugs, these companies seek to maximize revenue streams while delaying the entry of low-cost generic alternatives
However, 69 T2DM patients receiving metformin were also given either exenatide ( n = 36) or insulin glargine ( n = 33)
Beyond that difference, Zepbound and Mounjaro are very similar
A -actin antibody (A5441, Sigma, 1:4000) was used as a loading control
I didn't want to take the risk
US$ 26.39
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 21.33
US$ 24.13
US$ 24.50
US$ 20.99
US$ 27.97
US$ 20.86
